HORIZON GOVERNMENT AFFAIRS

Lobbying for AMICUS THERAPEUTICS, INC. · Biopharmaceutical Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $10,000.00 income · posted Oct 2, 2025

Lobbying activity 1

Health Issues

newborn screening, prescription drug affordability

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem